TY  - CHAP
M1  - Book, Section
TI  - Chapter 34. Thrombotic Microangiopathies
A1  - Nast, Cynthia C.
A1  - Adler, Sharon G.
A2  - Lerma, Edgar V.
A2  - Berns, Jeffrey S.
A2  - Nissenson, Allen R.
Y1  - 2009
N1  - 
T2  - CURRENT Diagnosis & Treatment: Nephrology & Hypertension
AB  - The  thrombotic  microangiopathies  (TMAs)  are  classified  together  due  to  their  overlapping  clinical  and  morphologic  findings.  Their  major  clinical  manifestations  include  hemolytic  anemia,  microvascular  thrombosis,  and  thrombocytopenia.  Most  TMAs  have  renal  involvement  with  similar  morphologic  changes  in  the  kidney  reflecting  the  vasculopathy  these  lesions  share.  There  are  a  number  of  underlying  etiologic  factors  inducing  TMA  including  systemic  diseases,  infection,  and  medications,  which  are  summarized  in  Table  34–1.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=6336929
ER  -